Xanthine oxidase inhibition for chronic heart failure: is allopurinol the next therapeutic advance in heart failure?
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 15894755.
- Also identified by PMC identifier 1768957.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A substantial body of evidence has accumulated to suggest a role for the xanthine oxidase metabolic pathway in the pathophysiology of chronic heart failure and other cardiovascular diseases.
Medical subject headings
- Allopurinol
- Cardiac Output, Low
- Enzyme Inhibitors
- Xanthine Oxidase